Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000315758 | SCV000413303 | uncertain significance | Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002521237 | SCV003645666 | uncertain significance | Inborn genetic diseases | 2022-09-14 | criteria provided, single submitter | clinical testing | The c.4112C>G (p.P1371R) alteration is located in exon 31 (coding exon 31) of the LTBP4 gene. This alteration results from a C to G substitution at nucleotide position 4112, causing the proline (P) at amino acid position 1371 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |